To help combat antimicrobial resistance, the World Health Organization (WHO) launched the AWaRe portal which divides antibiotics into three groups – Access, Watch and Reserve.
Researchers investigated the mode of action of a new class of antibiotics that is highly effective against multidrug-resistant pathogens. Fibupeptides impair the energy supply to the bacterial cell, consequently causing their death.
Efforts are being made worldwide to reduce the rise and spread of antibiotic-resistant superbugs.
Researechers created a mix of three phages that have been genetically-modified using CRISPR.
Researchers used metagenomic next-generation sequencing to longitudinally assess the gut microbiota and antimicrobial resistomes of international travelers.
A consortium of14 organizations will develop an Australia-wide antimicrobial resistance knowledge engine to anticipate outbreaks and inform interventions.
The World Health Organization’s (WHO) Science Division has launched an online resource, the Health Product Profile Directory, to guide the development of new health products for which there are limited markets or incentives for research and development.
Although new antibiotics are very much needed, they will only be most effective if they’re used sparingly — for the most critical of cases. This presents serious economic challenges to developing antibiotics.
The United Nations, international agencies, and experts have released a report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
This report presents the IACG’s response to the request from Member States in the 2016 political declaration and makes recommendations for urgent action for consideration by the Secretary-General, Member States and other stakeholders in the global response to antimicrobial resistance.